Price Alert: Shares of ProQR N.V (PRQR) Trade 5.65% Higher at Midday June 21

Equities Staff  |

ProQR Therapeutics N.V (NASDAQ: PRQR) has climbed $0.0414 (5.65%) and is currently sitting at $0.77, as of 11:49:24 est on June 21.

231,301 shares exchanged hands.

The Company is down 2.08% over the last 5 days and shares have risen 8.75% over the last 30 days.

ProQR N.V expects its next earnings on 2022-08-04.

For technical charts, analysis, and more on ProQR N.V visit the company profile.

About ProQR Therapeutics N.V

ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Based on its unique proprietary RNA repair platform technologies, the Company is growing its pipeline with patients and loved ones in mind.

To get more information on ProQR Therapeutics N.V and to follow the company's latest updates, you can visit the company's profile page here: ProQR Therapeutics N.V's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content